Cargando…
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
OBJECTIVES: In recent years, a number of structurally diverse Histone deacetylase (HDAC) inhibitors have been identified and these HDAC inhibitors induce growth arrest, differentiation and/or apoptosis of cancer cells in vitro and in vivo. This study aimed at investigating the anti-tumor activity of...
Autores principales: | Min, Kyung Nan, Joung, Ki Eun, Kim, Dae-Kee, Sheen, Yhun Yhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Environmental Health and Toxicology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355273/ https://www.ncbi.nlm.nih.gov/pubmed/22639737 http://dx.doi.org/10.5620/eht.2012.27.e2012010 |
Ejemplares similares
-
Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer
por: Joung, Ki Eun, et al.
Publicado: (2012) -
Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012) -
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor
por: Park, Jiyoung, et al.
Publicado: (2022) -
(7-Dimethylamino-1-hydroxy-3-naphthyl)(morpholino)methanone
por: Kim, Moon-Hwan, et al.
Publicado: (2009) -
Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
por: Park, So-Yeon, et al.
Publicado: (2015)